Qingping Jiang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Obstetrics and Gynecology top 10%
- Endometrial and Cervical Cancer Treatments
Papers in ⓘ
-
- Circular RNAs in diseases 10
- RNA Research and Splicing 4
- RNA modifications and cancer 4
-
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 14
- Co-authors
- Weiyi Fang (11 shared papers)Shaoyan Liu (13 shared papers)Hanzhen Xiong (13 shared papers)Xuehu Xu (5 shared papers)Ruichao Chen (6 shared papers)Chao Cheng (4 shared papers)Xuan Zhou (2 shared papers)Qiaofen Fu (3 shared papers)
- Journals
- Oncotarget (2 papers)Cell Death and Disease (2 papers)BMC Cancer (2 papers)Diagnostic Pathology (2 papers)Disease Markers (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Qingping Jiang
42 papers receiving 827 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 502
- Obstetrics and Gynecology 70
- Molecular Biology 601
- Reproductive Medicine 71
- Oncology 154
Countries citing papers authored by Qingping Jiang
This map shows the geographic impact of Qingping Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingping Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingping Jiang more than expected).
Fields of papers citing papers by Qingping Jiang
This network shows the impact of papers produced by Qingping Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingping Jiang. The network helps show where Qingping Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Qingping Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 111 | |
| 2 | 2016 | 110 | |
| 3 | 2018 | 45 | |
| 4 | 2014 | 43 | |
| 5 | 2010 | 42 | |
| 6 | The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer. | 2015 | 38 |
| 7 | 2018 | 36 | |
| 8 | 2014 | 35 | |
| 9 | 2020 | 33 | |
| 10 | 2016 | 32 | |
| 11 | ZEB1 promotes invasion and metastasis of endometrial cancer by interacting with HDGF and inducing its transcription. | 2019 | 29 |
| 12 | 2015 | 25 | |
| 13 | 2012 | 20 | |
| 14 | 2017 | 17 | |
| 15 | 2021 | 16 | |
| 16 | 2014 | 16 | |
| 17 | 2012 | 16 | |
| 18 | 2015 | 15 | |
| 19 | 2017 | 15 | |
| 20 | 2017 | 14 |
About Qingping Jiang
Qingping Jiang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Obstetrics and Gynecology, having authored 43 papers that have together received 833 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (14 papers), Circular RNAs in diseases (10 papers), RNA Research and Splicing (4 papers), RNA modifications and cancer (4 papers), Viral-associated cancers and disorders (3 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Cancer Research (502 citations), Obstetrics and Gynecology (70 citations), Molecular Biology (601 citations), Reproductive Medicine (71 citations) and Oncology (154 citations). Qingping Jiang has collaborated with scholars based in China and United States. Frequent co-authors include Weiyi Fang, Shaoyan Liu, Hanzhen Xiong, Xuehu Xu, Ruichao Chen, Chao Cheng, Xuan Zhou, Qiaofen Fu, Fang Wang and Shangbiao Wu. Their work appears in journals such as Oncotarget, Cell Death and Disease, BMC Cancer, Diagnostic Pathology and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.